Cargando…

Role of Altered Metabolism of Triglyceride-Rich Lipoprotein Particles in the Development of Vascular Dysfunction in Systemic Lupus Erythematosus

Background: Impaired lipid metabolism contributes to accelerated inflammatory responses in addition to promoting the formation of atherosclerosis in systemic lupus erythematosus (SLE). We aimed to evaluate the lipid profile, inflammatory markers, and vascular diagnostic tests in active SLE patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diószegi, Ágnes, Lőrincz, Hajnalka, Kaáli, Eszter, Soltész, Pál, Perge, Bianka, Varga, Éva, Harangi, Mariann, Tarr, Tünde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046254/ https://www.ncbi.nlm.nih.gov/pubmed/36979336 http://dx.doi.org/10.3390/biom13030401

Ejemplares similares

High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus
por: Gaál, Krisztina, et al.
Publicado: (2016)

Changes in Clinical Manifestations and Course of Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome over Three Decades
por: Nagy, Nikolett, et al.
Publicado: (2023)

Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions
por: Juhász, Lilla, et al.
Publicado: (2023)

Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients
por: Szentpéteri, Anita, et al.
Publicado: (2018)

Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects
por: Somodi, Sándor, et al.
Publicado: (2018)

Gender-Dependent Associations between Serum Betatrophin Levels and Lipoprotein Subfractions in Diabetic and Nondiabetic Obese Patients
por: Lőrincz, Hajnalka, et al.
Publicado: (2023)

Low Levels of Serum Fetuin-A and Retinol-Binding Protein 4 Correlate with Lipoprotein Subfractions in Morbid Obese and Lean Non-Diabetic Subjects
por: Lőrincz, Hajnalka, et al.
Publicado: (2021)

Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
por: Berta, Eszter, et al.
Publicado: (2022)

Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
por: Zhang, Bai-Hui, et al.
Publicado: (2022)

Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia
por: Juhász, Lilla, et al.
Publicado: (2022)

Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity
por: Lőrincz, Hajnalka, et al.
Publicado: (2023)

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
por: Varga, Viktória E., et al.
Publicado: (2016)

Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients
por: Fülöp, Péter, et al.
Publicado: (2014)

Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy
por: Nádró, Bíborka, et al.
Publicado: (2021)

Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia
por: Nádró, Bíborka, et al.
Publicado: (2022)

Afamin Levels and Their Correlation with Oxidative and Lipid Parameters in Non-diabetic, Obese Patients
por: Juhász, Imre, et al.
Publicado: (2022)

PCSK9 and triglyceride-rich lipoprotein metabolism
por: Druce, Irena, et al.
Publicado: (2015)

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
por: Dallinga-Thie, Geesje M., et al.
Publicado: (2016)

Changes in serum pigment epithelium-derived factor levels after kidney transplantation in patients with end-stage renal disease
por: Szentimrei, Réka, et al.
Publicado: (2022)

Triglyceride-rich lipoproteins prevent septic death in rats
Publicado: (1995)

Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
por: Visser, Jolien, et al.
Publicado: (2022)

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
por: Baratta, Francesco, et al.
Publicado: (2023)

Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
por: Heo, Ji Hye, et al.
Publicado: (2023)

Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
por: Gugliucci, Alejandro
Publicado: (2023)

Impaired Organokine Regulation in Non-Diabetic Obese Subjects: Halfway to the Cardiometabolic Danger Zone
por: Lőrincz, Hajnalka, et al.
Publicado: (2023)

The Importance of Arterial Stiffness Assessment in Patients with Familial Hypercholesterolemia
por: Kovács, Beáta, et al.
Publicado: (2022)

Assessment of Hypertensive Patients’ Complex Metabolic Status Using Data Mining Methods
por: Kovács, Beáta, et al.
Publicado: (2023)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
por: Toth, Peter P
Publicado: (2016)

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy
por: Srivastava, Anand, et al.
Publicado: (2016)

Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy
por: Reiner, Željko
Publicado: (2018)

Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins
por: Khetarpal, Sumeet A., et al.
Publicado: (2021)

The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease
por: Gabani, Mohanad, et al.
Publicado: (2023)

Fatal CMV-Infection after Autologous Stem Cell Transplantation in Refractory Systemic Lupus Erythematosus
por: Váróczy, László, et al.
Publicado: (2012)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)

The Potential Diagnostic and Predictive Role of HbA1c in Diabetic, Septic Patients: A Retrospective Single-Center Study
por: Juhász, Imre, et al.
Publicado: (2022)

Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans
por: Adiels, Martin, et al.
Publicado: (2015)

Delayed clearance of triglyceride‐rich lipoproteins in young, healthy obese subjects
por: Larsen, M. A., et al.
Publicado: (2015)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
por: Borén, Jan, et al.
Publicado: (2020)

A simplified procedure to trace triglyceride‐rich lipoprotein metabolism in vivo
por: Ying, Zhixiong, et al.
Publicado: (2021)

Correlation of Triglyceride-Rich Lipoprotein Cholesterol and Diabetes Mellitus in Stroke Patients
por: Luo, Ruiqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v5gptp257dvqr7321uan9218au